Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 2 1

Status

Completed 3Unknown 1

Sponsor Class

OTHER 3

Study Type

Interventional 2Observational 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Stomach Neoplasms 1Polycystic Ovary Syndrome 1Oligomenorrhea 1Insulin Resistance 1Hyperandrogenism 1Hirsutism 1Esophageal Neoplasms 1Diabetes Mellitus, Type 1 1Cognitive Dysfunction 1

Interventions

Cyclophosphamide 1499Cisplatin 1435Paclitaxel 1340Radiotherapy 1310Carboplatin 1267Gemcitabine 1226Docetaxel 1133Bevacizumab 1070Fluorouracil 906Doxorubicin 805Dexamethasone 755Rituximab 744Capecitabine 735Oxaliplatin 709pembrolizumab 700Etoposide 679Irinotecan 639Filgrastim 624Cytarabine 587Nivolumab 586Leucovorin 583Vincristine 517Cetuximab 479Prednisone 478Bortezomib 474Trastuzumab 468Erlotinib Hydrochloride 467Surveys and Questionnaires 460Methotrexate 444Lenalidomide 436

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Completed × Time × Clear all
NCT04669301 2025-07-15

Memory and Attention Adaptation Training-Geriatrics (MAAT-G) Phase II

University of Rochester

Phase NA Completed
72 enrolled 15 charts

Cognitive Dysfunction

NCT04979377 2025-03-17

Prevalence of Hyperandrogenism in Type 1 Diabetes

Fundacion para la Investigacion Biomedica del Hospital Universitario Ramon y Cajal

Completed
150 enrolled

Diabetes Mellitus, Type 1, Hirsutism, Insulin Resistance, Oligomenorrhea, Polycystic Ovary Syndrome, Hyperandrogenism

NCT00737438 2016-02-03

Pre-operative Chemotherapy Plus Bevacizumab With Early Salvage Therapy Based on PET Assessment of Response in Patients With Locally Advanced But Resectable Gastric and GEJ Adenocarcinoma

Memorial Sloan Kettering Cancer Center

Phase 2 Completed
22 enrolled 6 charts
Gastrointestinal

Esophageal Neoplasms, Stomach Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡